Stay updated on TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:39:53.000Z thumbnail image
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the efficacy evaluation of nivolumab plus TG4010 in previously treated patients with non-small cell lung cancer, focusing on the objective response rate and safety profile.
    Difference
    0.1%
    Check dated 2024-06-06T14:21:50.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed explanation of eligibility criteria for clinical research, including examples such as general health condition or prior treatments. Additionally, specific inclusion criteria for a study on non-squamous NSCLC have been outlined, including requirements for histological confirmation and specific genetic testing.
    Difference
    45%
    Check dated 2024-05-22T19:33:15.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:39:58.000Z thumbnail image

Stay in the know with updates to TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.